Cyril Franklyn Halbert, MD | |
2131 E State St, Athens, OH 45701-2138 | |
(740) 589-3100 | |
(740) 589-3123 |
Full Name | Cyril Franklyn Halbert |
---|---|
Gender | Male |
Speciality | Plastic Surgery |
Location | 2131 E State St, Athens, Ohio |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003992660 | NPI | - | NPPES |
3810026950 | Medicaid | WV | |
0989702 | Medicaid | OH |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208200000X | Plastic Surgery | 35.0666045 (Ohio) | Primary |
Mailing Address | Practice Location Address |
---|---|
Cyril Franklyn Halbert, MD 2131 E State St, Athens, OH 45701-2138 Ph: (740) 589-3100 | Cyril Franklyn Halbert, MD 2131 E State St, Athens, OH 45701-2138 Ph: (740) 589-3100 |
News Archive
The International Association for the Study of Lung Cancer (IASLC) is once again gratified to see the approval of a new second-generation lung cancer treatment that can help many patients in their battle against the disease.
WBUR (Boston, Mass.): The two main "safety net" hospitals in Massachusetts are facing the prospect of a financial crisis without federal assistance in the next few days to close their books. "Cambridge Health Alliance will break even if the feds approve a Medicaid waiver amendment worth $86 million this year.
Duke University Medical Center and National Cancer Institute scientists have discovered that a novel genetic alteration - a second copy of an entire gene - is a cause of familial chordoma, an uncommon form of cancer arising in bones and frequently affecting the nervous system.
RegeneRx Biopharmaceuticals, Inc. announced that its strategic partner, G-treeBNT Co. Ltd., has filed an IND with the Korean Ministry of Food and Drug Safety for a Phase IIB/III clinical trial with RGN-259 (designated GBT-201 in Korea and the licensed Pan Asia territory) for the treatment of patients with dry eye syndrome.
An important clinical repercussion in the treatment of epilepsy has been discovered by a research team led by Scott Mintzer, M.D., assistant professor in the Department of Neurology and the Jefferson Comprehensive Epilepsy Center at Jefferson Medical College of Thomas Jefferson University.
› Verified 6 days ago